Wird geladen...
Metabolomic Biomarkers for Detection, Prognosis and Identifying Recurrence in Endometrial Cancer
Metabolic reprogramming is increasingly recognised as one of the defining hallmarks of tumorigenesis. There is compelling evidence to suggest that endometrial cancer develops and progresses in the context of profound metabolic dysfunction. Whilst the incidence of endometrial cancer continues to rise...
Gespeichert in:
| Veröffentlicht in: | Metabolites |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7463916/ https://ncbi.nlm.nih.gov/pubmed/32751940 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/metabo10080314 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|